Samsung Bioepis has just reached a thrilling milestone by securing Japan’s regulatory approval for its Stelara biosimilar, opening the door to a powerful presence in Asia’s rapidly growing biologics market, The Korea Herald reports
Browsing: Biopharmaceuticals
SAFE has teamed up with Vortrom Biologics in a dynamic distribution partnership, paving the way to expand its presence across Spain and deliver groundbreaking biopharmaceutical innovations directly to communities throughout the region
Celltrion USA is excited to announce the U.S. debut of its denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo), offering innovative and powerful new solutions for osteoporosis and bone health management
Exciting news from Lipocine Inc.! The company has just unveiled a groundbreaking license and supply agreement for its innovative testosterone replacement therapy, TLANDO®, in Brazil. This strategic partnership is set to broaden access to this vital treatment across the Brazilian market, significantly boosting Lipocine’s presence on the global stage.
4Moving Biotech has secured a €7.6 million grant from France 2030 to advance its innovative, first-in-class disease-modifying drug for osteoarthritis. This funding will support the company’s efforts to transform treatment options for this widespread condition.